会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Vaccines for suppressing ige-mediated allergic disease and methods for using the same
    • 用于抑制ige介导的过敏性疾病的疫苗及其使用方法
    • US20060052592A1
    • 2006-03-09
    • US10518701
    • 2003-06-20
    • Arnold LevinsonSandra CalarotaDavid WeinerMiguel Otero
    • Arnold LevinsonSandra CalarotaDavid WeinerMiguel Otero
    • A61K48/00C07H21/02C07H21/04
    • A61K39/0005A61K39/00A61K39/08A61K2039/505A61K2039/53C07K16/00C07K2317/52C07K2318/10C07K2319/55
    • Nucleic acid molecules that encode a protein comprising at least one epitope of membrane IgE free of epitopes present on the serum IgE, including proteins that further comprise non-IgE T cell helper epitope are disclosed. Vaccines, vectors and host cells that comprise such nucleic acid molecules are disclosed. Isolated proteins, including haptenized proteins, comprising at least one epitope of membrane IgE free of epitopes present on the serum IgE, including proteins that further comprise non-IgE T cell helper epitope are disclosed. Vaccines that comprise and methods of making such proteins and antibodies that specifically bind to such proteins are disclosed. Killed or inactivated cells or particles, including haptenized killed or inactivated cells or particles, that comprise a protein comprising at least one epitope of membrane IgE free of epitopes present on the serum IgE, including proteins that further comprise non-IgE T cell helper epitope are disclosed. Vaccines that comprise such killed or inactivated cells or particles are disclosed. Methods of treating and preventing IgE mediated allergic disease or condition are disclosed.
    • 公开了编码蛋白质的核酸分子,其包含不含存在于血清IgE上的表位的膜IgE的至少一个表位,包括进一步包含非IgE T细胞辅助表位的蛋白质。 公开了包含这种核酸分子的疫苗,载体和宿主细胞。 公开了分离的蛋白质,包括半抗体蛋白质,其包含至少一个不含存在于血清IgE上的表位的膜IgE表位,包括进一步包含非IgE T细胞辅助因子表位的蛋白质。 公开了包含制备这种蛋白质和特异性结合这些蛋白质的抗体的方法的疫苗。 杀伤或灭活的细胞或颗粒,包括半抗原的灭活或灭活的细胞或颗粒,其包含蛋白质的至少一个表位,所述蛋白质包含血清IgE上存在的表位的膜IgE的至少一个表位,包括进一步包含非IgE T细胞辅助表位的蛋白质 披露 公开了包含这种杀死或灭活的细胞或颗粒的疫苗。 公开了治疗和预防IgE介导的过敏性疾病或病症的方法。